Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. 1994

J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
Department of Medicine, Kuopio University Hospital, Finland.

OBJECTIVE To determine the association between the e4 allele of apolipoprotein E and Alzheimer's disease in a randomly selected population sample. METHODS Cross sectional population based study. METHODS 980 people aged 69 to 78 (349 men, 631 women). METHODS Population of Kuopio, eastern Finland. METHODS Presence of e4 allele and diagnosis of Alzheimer's disease by detailed neurological and neurophysiological evaluation. RESULTS 46 (4.7%) subjects were classified as having probable or possible Alzheimer's disease. The frequency of the apolipoprotein E e4 allele was 0.359 in patients with Alzheimer's disease and 0.165 subjects without dementia (P < 0.0001). The prevalence of Alzheimer's disease was 2.9% in subjects with no e4 alleles, 7.6% in subjects with one e4 allele, and 21.4% in subjects with two e4 alleles of apolipoprotein E. CONCLUSIONS Allele e4 of apolipoprotein is associated with Alzheimer's disease in a dose-response fashion in a randomly selected elderly population.

UI MeSH Term Description Entries
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
September 1994, American journal of medical genetics,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
January 1997, Biological psychiatry,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
August 1993, Neurology,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
October 1994, Annals of neurology,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
August 1997, Neuroscience letters,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
October 1996, Journal of neurology, neurosurgery, and psychiatry,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
July 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
May 1995, Neurology,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
February 2006, Chinese medical journal,
J Kuusisto, and K Koivisto, and K Kervinen, and L Mykkänen, and E L Helkala, and M Vanhanen, and T Hänninen, and K Pyörälä, and Y A Kesäniemi, and P Riekkinen
January 1998, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!